Description

4-[[(6Ar)-6Aβ,7,10,10Aα-Tetrahydro-6,6,9-Trimethyl-3-Pentyl-6H-Dibenzo[B,D]Pyran-1-Yl]Oxy]-1-Butanamine is a high-purity synthetic cannabinoid derivative with a complex heterocyclic structure. This compound is of significant interest for advanced pharmaceutical research and development, particularly in the study of cannabinoid receptor pharmacology. It is primarily utilized by research institutions, pharmaceutical companies, and chemical manufacturers engaged in the synthesis of novel therapeutic agents and reference standards.

Application

• Pharmaceutical R&D Intermediate: Serves as a key synthetic precursor or reference standard in the development of novel cannabinoid-based therapeutics.
• Biochemical Research: Used in in vitro and in vivo studies to investigate cannabinoid receptor (CB1/CB2) binding affinity, selectivity, and downstream signaling pathways.
• Reference Standard: Employed as a high-purity analytical standard for method development, validation, and quality control in analytical laboratories.
• Medicinal Chemistry: A valuable building block for structure-activity relationship (SAR) studies to optimize pharmacokinetic and pharmacodynamic properties.
• Chemical Synthesis: Acts as a specialized intermediate for the synthesis of more complex, targeted cannabinoid analogs.

Basic Information

Product Name	4-[[(6Ar)-6Aβ,7,10,10Aα-Tetrahydro-6,6,9-Trimethyl-3-Pentyl-6H-Dibenzo[B,D]Pyran-1-Yl]Oxy]-1-Butanamine
CAS No.	132213-87-7
Molecular Formula	C27H41NO2
Molecular Weight	411.62 g/mol
Synonyms	1-Butanamine, 4-[[(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl]oxy]-; 4-[(6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl]oxy-1-butanamine; AM-2232; 1-[(6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-yl]oxy-4-butanamine; Cannabinoid AM-2232; CB1 Receptor Agonist AM-2232
EINECS	Contact for details

Quality Control

Our 4-[[(6Ar)-6Aβ,7,10,10Aα-Tetrahydro-6,6,9-Trimethyl-3-Pentyl-6H-Dibenzo[B,D]Pyran-1-Yl]Oxy]-1-Butanamine is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, GC for residual solvents, and spectroscopic identification (IR, NMR, MS), to ensure it meets the stringent requirements for research and development. Certificates of Analysis (COA) with detailed chromatograms and spectral data are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store under an inert atmosphere (e.g., nitrogen or argon) at controlled room temperature (15-25°C) in a cool, dry, and well-ventilated place. Due to its hygroscopic nature, the container must be kept tightly sealed to minimize exposure to moisture.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Water Content (KF)	≤ 0.5%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.